10.1002/adsc.201800625
Advanced Synthesis & Catalysis
scope of this methodology are currently in progress in
our laboratory.
Science 2007, 317, 1881; g) T. Furuya, A. S. Kamlet, T.
Ritter, Nature 2011, 473, 470; h) M. Morgenthaler, E.
Schweizer, A. Hoffmann-Röder, F. Benini, R. E.
Martin, G. Jaeschke, B. Wagner, H. Fischer, S. Bendels,
D. Zimmerli, J. Schneider, F. Diederich, M. Kansy, K.
Müller, ChemMedChem 2007, 2, 1100.
Experimental Section
General
trifluoromethylation
butanesulfinyl ketimines 2 with TMSCF3 1
procedure
for
the
asymmetric
N-tert-
[3] a) Z.-J. Liu, J.-T. Liu, Chem. Commun. 2008, 5233; b)
M. Kawatsura, S. Terasaki, M. Minakawa, T. Hirakawa,
K. Ikeda, T. Itoh, Org. Lett. 2014, 16, 2442; c) G. K. S.
Prakash, M. Mandal, G. A. Olah, Org. Lett. 2001, 3,
2847; d) N. T. N. Tam, G. Magueur, M. Ourévitch, B.
Crousse, J.-P. Bégué, D. Bonnet-Delpon, J. Org. Chem.
2005, 70, 699; e) S. D. Kuduk, C. N. D. Marco, S. M.
Pitzenberger, N. Tsou, Tetrahedron Lett. 2006, 47,
2377; f) S. Fries, J. Pytkowiz, T. Brigaud, Tetrahedron
Lett. 2005, 46, 4761; g) S. Fustero, J. García Soler, A.
Bartolomé, M. Sánchez Roselló, Org. Lett. 2003, 5,
2707; h) G. Magueur, B. Crousse, D. Bonnet-Delpon,
Eur. J. Org. Chem. 2008, 1527.
of
α,β-unsaturated
In a glove box, α,β-unsaturated N-tert-butanesulfinyl
ketimines (R)-2 (0.1 mmol) and CsF (0.11 mmol) were
added to a reaction tube that is equipped with a stirring bar.
The tube was capped with a septum and taken out. Under
an atmosphere of N2, THF (2.0 mL) was added and the
mixture was stirring for 10 minutes at 0oC. Next, TMSCF3
1 (0.5 mmol) was added by syringe and the reaction
solution was stirred at 0oC for 5 h then quenched with
saturated aqueous NH4Cl solution (2 mL). The resulting
mixture was extracted with EtOAc (10 mL x 3). The
combined organic solution was dried over Na2SO4. After
the removal of volatile solvents under vacuum, the crude
product was further purified by silica gel column
chromatography (petroleum ether / EtOAc = 5:1 as eluent)
to give product 3.
[4] a) K. Morisaki, M. Sawa, J.-y. Nomaguchi, H.
Morimoto, Y. Takeuchi, K. Mashima, T. Ohshima,
Chem. Eur. J. 2013, 19, 8417; b) Y. Yang, Y. Huang,
F.-L. Qing, Tetrahedron Lett. 2013, 54, 3826.
Acknowledgements
Financial support from the National Natural Science Foundation
of China (Nos. 21102093, 21472126, 21672151), the
Science and Technology Commission of Shanghai Municipality
(No. 15DZ1942203), the Innovation Program of Shanghai
Municipal Education Commission (No. 14YZ144), Chemical
Engineering and Technology (Perfume and Aroma Technology)
of Shanghai Plateau Discipline and Shanghai Institute of
Technology (No. XTCX2016-5) is gratefully acknowledged.
[5] P. Liu, Z.-J. Liu, F. H. Wu, Adv. Synth. Catal. 2015,
357, 818.
[6] a) F. Zhang, Z.-J. Liu, J.-T. Liu, Org. Biomol. Chem.
2011, 9, 3625; b) X.-M. Yuan, J. Xu, Z.-J. Liu, X.-J.
Yang, L.-M. Wang, Y. Zhang, X.-Y. Yang, X.-P. He,
J.-T. Liu, J. Fluorine Chem. 2012, 144, 102; c) P. Li, M.
Jiang, J.-T. Liu, Chin J Chem. 2014, 32, 1003.
[7] a) X. Liu, C. Xu, M. Wang, Q. Liu, Chem. Rev. 2015,
115, 683; b) X. Yang, T. Wu, R. J. Phipps, F. D. Toste,
Chem. Rev. 2015, 115, 826; c) see ref. 2c; d) J.-A. Ma,
D. Cahard, J. Fluorine Chem. 2007, 128, 975; e) G. K.
S. Prakash, M. Mandal, J. Fluorine Chem. 2001, 112,
123; f) R. P. Singh, J. M. Shreeve, Tetrahedron 2000,
56, 7613; g) G. K. S. Prakash, A. K. Yudin, Chem. Rev.
1997, 97, 757.
References
[1] a) R. Filler, Y. Kobayashi, Y. L. Yagulpolskii,
Organoflurine Compounds in Medicinal Chemistry and
Biomedical Applications; Elsevier: Amsterdam, 1993;
b) R. E. Banks, B. E. Smart, J. C. Tatlow,
Organoflurine Chemistry: Principles and Commercial
Applications; Plenum Presss: New York, 1994; c) J.-P.
Bégué, D. Bonnet-Delpon, Bioorganic and Medicinal
Chemistry of Fluorine; Wiley: Hoboken, New York,
2008; d) J. W. Corbett, S. S. Ko, J. D. Rodgers, S.
Jeffrey, L. T. Bacheler, R. M. Klabe, S. Diamond, C. M.
Lai, S. R. Rabel, J. A. Saye, S. P. Adams, G. L. Trainor,
P. S. Anderson, S. K. Erickson-Viitanen, Antimicrob.
Agents Chemother. 1999, 43, 2893; e) J. W. Corbett, S.
S. Ko, J. D. Rodgers, L. A. Gearhart, N. A. Magnus, L.
T. Bacheler, S. Diamond, S. Jeffrey, R. M. Klabe, B. C.
Cordova, S. Garber, K. Logue, G. L. Trainor, P. S.
Anderson, S. K. Erickson-Viitanen, J. Med. Chem.
2000, 43, 2019.
[8] a) G. K. S. Prakash, M. Mandal, G. A. Olah, Angew.
Chem. 2001, 113, 609; Angew. Chem. Int. Ed. 2001, 40,
589; b)see ref. 3c; c) G. K. S. Prakash, M. Mandal, J.
Am. Chem. Soc. 2002, 124, 6538; d) W. Xu, W. R., Jr.
Dolbier, J. Org. Chem. 2005, 70, 4741; e) C. Estivill, J.
Mendizabal, A. Virgili, E. Monteagudo, T. Flor, F.
Sánchez-Ferrando, A. Alvarez-Larena, J. F. Piniella,
Tetrahedron 2009, 65, 171; f) H. Kawai, A. Kusuda, S.
Nakamura, M. Shiro, N. Shibata, Angew. Chem. 2009,
121, 6442; Angew. Chem. Int. Ed. 2009, 48, 6324; g) S.
Okusu, H. Kawai, X.-H. Xu, E. Tokunaga, N. Shibata,
J. Fluorine Chem. 2012, 143, 216; h) L. Bernardi, E.
Indrigo, S. Pollicino, A. Ricci, Chem. Commun. 2012,
48, 1428; i) Y. Kawano, T. Mukaiyama, Chem. Lett.
2005, 34, 894.
[2] a) I. Ojima, Fluorine in Medicinal Chemistry and
Medicinal Biology, Wiley-Blackwell, Chichester, 2009;
b) J. T. Welch, S. Eshwarakrishman, Fluorine in
Bioorganic Chemistry, Wiley, New York, 1991; c) J.
Liu, J. Hu, Future Med. Chem. 2009, 1, 875; d) Y.
Zhou, J. Wang, Z. Gu, S. Wang, W. Zhu, J. L. Aceña V.
A. Soloshonok, K. Izawa, H. Liu, Chem. Rev. 2016,
116, 422; e) E. Merino, C. Nevado, Chem. Soc. Rev.
2014, 43, 6598; f) K. Müller, C. Faeh, F. Diederich,
[9] a) Only one example for the asymmetric
trifluoromethylation of “double” activated ketimines
derived from isatins and N-tert-butanesulfinamide has
been reported and very low diastereoselectivities (2:1
dr or lower) were observed, see: D. Chen, M.-H. Xu, J.
Org. Chem. 2014, 79, 7746. For the racemic
5
This article is protected by copyright. All rights reserved.